PD-L1 on cancer cells can prevent the activation and recruitment of immune cells in lymph nodes by binding to the PD1 receptor on T cells, thus helping cancer cells escape the surveillance of the immune system (Chen and Mellman, 2013). The gene discussed is CD274; the disease is cancer.